Advanced Drug Designing: Traditional and In Silico

The aim of “Drug Designing: Traditional and In Silico” is to equip students with the knowledge and skills to integrate traditional medicinal chemistry methods with advanced computational techniques for the discovery and optimization of novel pharmaceutical agents. By understanding the principles underlying both approaches, students are prepared to contribute to the development of innovative therapies, addressing unmet medical needs and advancing drug discovery efforts.

• Provide a comprehensive understanding of traditional medicinal chemistry methods used in drug discovery.
• Introduce students to advanced computational techniques for in silico drug design and screening.
• Explore the principles of molecular docking, pharmacophore modeling, and quantitative structure-activity relationship (QSAR) analysis.
• Familiarize students with the process of target identification and validation in drug discovery.
• Develop practical skills in designing, synthesizing, and optimizing lead compounds using both traditional and computational approaches.
• Equip students with the ability to assess the pharmacokinetic and toxicity profiles of potential drug candidates through virtual ADME-Tox assessment.
• Foster critical thinking and problem-solving skills in evaluating and prioritizing lead compounds for further preclinical and clinical development.
• Encourage interdisciplinary collaboration and communication among students from diverse backgrounds in pharmaceutical sciences, chemistry, and computational biology.

Pharmaceutical scientists, biotechnology professionals, academic researchers and students, healthcare professionals, IT and data science professionals in the domains of drug design, pharmacology, biotechnology, and computational biology.

1. Gain comprehensive knowledge of both traditional and computational drug design methods.
2. Develop expertise in molecular docking, pharmacophore modeling, and QSAR analysis.
3. Acquire hands-on experience with drug synthesis, optimization, and ADME-Tox assessments.
4. Be adept at using cutting-edge software and tools for in silico drug design.
5. Enhance problem-solving skills applicable to real-world drug development challenges.
6. Be prepared for advanced roles in pharmaceutical and biotechnology sectors.